1.46
price up icon8.96%   0.12
after-market After Hours: 1.46
loading
Talphera Inc stock is traded at $1.46, with a volume of 720.34K. It is up +8.96% in the last 24 hours and up +26.96% over the past month. Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
See More
Previous Close:
$1.34
Open:
$1.37
24h Volume:
720.34K
Relative Volume:
0.47
Market Cap:
$68.05M
Revenue:
$2.82M
Net Income/Loss:
$-14.20M
P/E Ratio:
-1.7176
EPS:
-0.85
Net Cash Flow:
$-15.13M
1W Performance:
+10.61%
1M Performance:
+26.96%
6M Performance:
+188.54%
1Y Performance:
+110.04%
1-Day Range:
Value
$1.34
$1.57
1-Week Range:
Value
$1.26
$1.57
52-Week Range:
Value
$0.38
$1.57

Talphera Inc Stock (TLPH) Company Profile

Name
Name
Talphera Inc
Name
Phone
650-216-3500
Name
Address
1850 GATEWAY DRIVE, SAN MATEO
Name
Employee
13
Name
Twitter
Name
Next Earnings Date
2024-11-06
Name
Latest SEC Filings
Name
TLPH's Discussions on Twitter

Compare TLPH with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
TLPH
Talphera Inc
1.46 62.46M 2.82M -14.20M -15.13M -0.85
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
122.87 53.79B 9.40B 2.65B 2.24B 5.935
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.22 45.18B 29.63B 260.53M 5.51B 0.0788
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.67 43.95B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
24.77 27.78B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
477.20 20.44B 3.08B 1.24B 1.07B 25.61

Talphera Inc Stock (TLPH) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-28-25 Initiated Rodman & Renshaw Buy
Jul-20-20 Downgrade Credit Suisse Neutral → Underperform
Nov-11-19 Downgrade Credit Suisse Outperform → Neutral
Aug-05-19 Resumed Credit Suisse Outperform
Jul-10-19 Resumed Credit Suisse Outperform
Apr-24-19 Resumed B. Riley FBR Buy
Feb-15-19 Initiated Credit Suisse Outperform
Oct-23-18 Initiated B. Riley FBR Buy
Oct-13-17 Downgrade Jefferies Buy → Hold
Oct-13-17 Reiterated RBC Capital Mkts Outperform
Jul-14-17 Resumed Jefferies Buy
Sep-15-16 Reiterated ROTH Capital Buy
Aug-05-16 Downgrade Stifel Buy → Hold
Oct-30-15 Upgrade Jefferies Hold → Buy
Oct-05-15 Reiterated ROTH Capital Buy
Sep-02-15 Initiated H.C. Wainwright Buy
Jul-10-15 Resumed ROTH Capital Buy
May-06-15 Reiterated Mizuho Neutral
May-05-15 Reiterated RBC Capital Mkts Outperform
Mar-10-15 Reiterated RBC Capital Mkts Outperform
Mar-09-15 Downgrade Mizuho Buy → Neutral
View All

Talphera Inc Stock (TLPH) Latest News

Talphera Inc Stock (TLPH) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$37.78
price up icon 8.84%
drug_manufacturers_specialty_generic RDY
$13.66
price down icon 1.80%
$23.09
price up icon 3.78%
$10.57
price up icon 1.05%
$141.25
price down icon 0.41%
$477.20
price up icon 0.50%
Cap:     |  Volume (24h):